199 related articles for article (PubMed ID: 17005282)
1. Intracellular binding of fukutin and alpha-dystroglycan: relation to glycosylation of alpha-dystroglycan.
Yamamoto T; Kawaguchi M; Sakayori N; Muramatsu F; Morikawa S; Kato Y; Shibata N; Kobayashi M
Neurosci Res; 2006 Dec; 56(4):391-9. PubMed ID: 17005282
[TBL] [Abstract][Full Text] [Related]
2. Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin.
Yamamoto T; Kato Y; Kawaguchi M; Shibata N; Kobayashi M
Med Electron Microsc; 2004 Dec; 37(4):200-7. PubMed ID: 15614444
[TBL] [Abstract][Full Text] [Related]
3. Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of alpha-dystroglycan.
Xiong H; Kobayashi K; Tachikawa M; Manya H; Takeda S; Chiyonobu T; Fujikake N; Wang F; Nishimoto A; Morris GE; Nagai Y; Kanagawa M; Endo T; Toda T
Biochem Biophys Res Commun; 2006 Dec; 350(4):935-41. PubMed ID: 17034757
[TBL] [Abstract][Full Text] [Related]
4. Expression of genes related to muscular dystrophy with lissencephaly.
Yamamoto T; Kato Y; Karita M; Kawaguchi M; Shibata N; Kobayashi M
Pediatr Neurol; 2004 Sep; 31(3):183-90. PubMed ID: 15351017
[TBL] [Abstract][Full Text] [Related]
5. Fukutin expression in mouse non-muscle somatic organs: its relationship to the hypoglycosylation of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
Saito Y; Yamamoto T; Ohtsuka-Tsurumi E; Oka A; Mizuguchi M; Itoh M; Voit T; Kato Y; Kobayashi M; Saito K; Osawa M
Brain Dev; 2004 Oct; 26(7):469-79. PubMed ID: 15351084
[TBL] [Abstract][Full Text] [Related]
6. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan.
Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I
Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426
[TBL] [Abstract][Full Text] [Related]
7. Subcellular localization of fukutin and fukutin-related protein in muscle cells.
Matsumoto H; Noguchi S; Sugie K; Ogawa M; Murayama K; Hayashi YK; Nishino I
J Biochem; 2004 Jun; 135(6):709-12. PubMed ID: 15213246
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of neurons and glia in the brain of Fukuyama type congenital muscular dystrophy.
Yamamoto T; Kato Y; Kawaguchi-Niida M; Shibata N; Osawa M; Saito K; Kröger S; Kobayashi M
Acta Myol; 2008 Jul; 27(1):9-13. PubMed ID: 19108571
[TBL] [Abstract][Full Text] [Related]
9. Co-localization of fukutin and alpha-dystroglycan in the mouse central nervous system.
Ohtsuka-Tsurumi E; Saito Y; Yamamoto T; Voit T; Kobayashi M; Osawa M
Brain Res Dev Brain Res; 2004 Sep; 152(2):121-7. PubMed ID: 15351499
[TBL] [Abstract][Full Text] [Related]
10. Altered glycosylation of alpha-dystroglycan in neurons of Fukuyama congenital muscular dystrophy brains.
Saito Y; Yamamoto T; Mizuguchi M; Kobayashi M; Saito K; Ohno K; Osawa M
Brain Res; 2006 Feb; 1075(1):223-8. PubMed ID: 16466646
[TBL] [Abstract][Full Text] [Related]
11. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy].
Toda T
Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766
[TBL] [Abstract][Full Text] [Related]
12. [Dystroglycan linkage and muscular dystrophy].
Shimizu T
Rinsho Shinkeigaku; 2002 Nov; 42(11):1091-4. PubMed ID: 12784674
[TBL] [Abstract][Full Text] [Related]
13. A role of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in cancer cells: a possible role to suppress cell proliferation.
Yamamoto T; Kato Y; Shibata N; Sawada T; Osawa M; Kobayashi M
Int J Exp Pathol; 2008 Oct; 89(5):332-41. PubMed ID: 18808525
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
[TBL] [Abstract][Full Text] [Related]
15. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
[TBL] [Abstract][Full Text] [Related]
16. Functions of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in neuromuscular system and other somatic organs.
Yamamoto T; Shibata N; Saito Y; Osawa M; Kobayashi M
Cent Nerv Syst Agents Med Chem; 2010 Jun; 10(2):169-79. PubMed ID: 20518731
[TBL] [Abstract][Full Text] [Related]
17. Fukutin expression in glial cells and neurons: implication in the brain lesions of Fukuyama congenital muscular dystrophy.
Yamamoto T; Kato Y; Karita M; Takeiri H; Muramatsu F; Kobayashi M; Saito K; Osawa M
Acta Neuropathol; 2002 Sep; 104(3):217-24. PubMed ID: 12172906
[TBL] [Abstract][Full Text] [Related]
18. Defective glycosylation of α-dystroglycan contributes to podocyte flattening.
Kojima K; Nosaka H; Kishimoto Y; Nishiyama Y; Fukuda S; Shimada M; Kodaka K; Saito F; Matsumura K; Shimizu T; Toda T; Takeda S; Kawachi H; Uchida S
Kidney Int; 2011 Feb; 79(3):311-6. PubMed ID: 20944549
[TBL] [Abstract][Full Text] [Related]
19. Basement membrane fragility underlies embryonic lethality in fukutin-null mice.
Kurahashi H; Taniguchi M; Meno C; Taniguchi Y; Takeda S; Horie M; Otani H; Toda T
Neurobiol Dis; 2005; 19(1-2):208-17. PubMed ID: 15837576
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
